Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC)
Yihe Yan, Leting Zheng, Qiang Du, Hamza O. Yazdani, Kun Dong, Yarong Guo, David A. Geller
Topics & Concepts
CXCL10CXCR3Cancer researchTumor microenvironmentIRF1BiologyChemokineParacrine signallingChemokine receptorTranscription factorImmunologyReceptorImmune systemTumor cellsBiochemistryGeneCancer Immunotherapy and BiomarkersImmune cells in cancerinterferon and immune responses